多奈哌齐治疗阿尔茨海默病的临床疗效研究.docVIP

多奈哌齐治疗阿尔茨海默病的临床疗效研究 【摘要】目的：验证多奈哌齐(Donepezil)治疗阿尔茨海默病(AD)的安 全性及有效性。方法：对61例AD患者进行多奈哌齐和他可林(Tacrirw)的多 中心开放、对照治疗,其中多奈哌齐组33例(5mg/d),他可林组28例(平均 100mg/d)；共治疗12周。应用简易精神状态检杳(MMSE),日常生活能力量 表(ADL)评定临床疗效，用副反应量表(TESS)评定副反应。结果：多奈哌齐 组治疗总有效率为69. 70%,显效率为51. 52%,他可林组分别为67. 86%和 46. 43%,起效时间均在治疗第四周末；两组间差异无显著性(X 2分别=0. 023 和0.011)o多奈哌齐组和他可林纽?治疗前厉MMSE评分及加分率，ADL评分及 减分率的差异均无显著性(P0.05)。多奈哌齐组的不良反应较他町林组显苦 少而轻，仅有6例病人存在轻度的恶心或胃纳减退。结论：多奈哌齐能有效治 疗AD,且不良反应少而轻微。 【关键词】阿尔茨海默病；多奈哌齐；他可林 A comparative study of donepezil and Alzheimer disease for Clinical research [abstract] Objective Verify thdt the Donepezil of many what Pains cures safe nature and effectiveness that. Ah vou Alzheimer disease ( AD ) . Methods But having more what the many centers open of neat and he forest ( Tacrine ) of Pay and contrast to 61 example AD pationts is cured , among them many what I Zoos Pay 33 examples (5mg/d ) , but his Lin Zu of 28 examples ( average lOOmg/d ) We should cure 12 weeks altogether ? Applying the simple and easy state of mind check ( MMSE ) , the day-to-day viability scalograra ( ADL ) is passd judgment on the clinical curative effect , with the byreaction scalogram ( TESS ) evaluation by-reaction ? ResuIts Many what Qi Zu Pai cure that but total availability for 51. 52%, shis forest component part not for 67. 86% is all curing the around end with 46? 43%, rises to imitate time for 69. 70%, s produce effects rate The difference does not have the significance (x 2 parts = 0. 023 and 0. 011 ) between two teams ? But many what Qi Zu Pai and his Lin Zu MMSE around curing gives a mark and adds the divides tdte, and ADL gives a mark to be reached difference that subtracts the divide rate all not to have the significance (P0? 05). But his Lin Zu is seldom notable and light to the many what bad reactions of I Zu Pay, and the nauseating or stomach that only has 6 example patients gently to cxist to spend is received to drop. Conclusions donepezilis an effective Treatment Medicine Alzheimer disease, with less side